NO20055443L - Stabilisert farmasoytisk produkt - Google Patents

Stabilisert farmasoytisk produkt

Info

Publication number
NO20055443L
NO20055443L NO20055443A NO20055443A NO20055443L NO 20055443 L NO20055443 L NO 20055443L NO 20055443 A NO20055443 A NO 20055443A NO 20055443 A NO20055443 A NO 20055443A NO 20055443 L NO20055443 L NO 20055443L
Authority
NO
Norway
Prior art keywords
pharmaceutical product
stabilized pharmaceutical
gasket
stabilized
protect
Prior art date
Application number
NO20055443A
Other languages
English (en)
Norwegian (no)
Inventor
Nicholas Heaton
Zoe Heaton
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Publication of NO20055443L publication Critical patent/NO20055443L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/06—Packaging for specific medical equipment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO20055443A 2003-05-28 2005-11-17 Stabilisert farmasoytisk produkt NO20055443L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0312148.0A GB0312148D0 (en) 2003-05-28 2003-05-28 Stabilized pharmaceutical products
PCT/GB2004/002249 WO2004105727A2 (fr) 2003-05-28 2004-05-27 Produit pharmaceutique stabilise

Publications (1)

Publication Number Publication Date
NO20055443L true NO20055443L (no) 2005-11-17

Family

ID=9958829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055443A NO20055443L (no) 2003-05-28 2005-11-17 Stabilisert farmasoytisk produkt

Country Status (22)

Country Link
US (4) US7736673B2 (fr)
EP (1) EP1626913B1 (fr)
JP (1) JP5175048B2 (fr)
KR (1) KR20060023539A (fr)
CN (1) CN1832890A (fr)
AR (1) AR047619A1 (fr)
AT (1) ATE457163T1 (fr)
AU (1) AU2004243223A1 (fr)
BR (1) BRPI0410701A (fr)
CA (1) CA2527088C (fr)
DE (1) DE602004025463D1 (fr)
ES (1) ES2340681T3 (fr)
GB (1) GB0312148D0 (fr)
MA (1) MA27804A1 (fr)
MX (1) MXPA05012757A (fr)
NO (1) NO20055443L (fr)
PL (1) PL1626913T3 (fr)
RS (1) RS20050882A (fr)
RU (1) RU2337667C2 (fr)
TW (1) TW200509989A (fr)
WO (1) WO2004105727A2 (fr)
ZA (1) ZA200509099B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
EP1635845A1 (fr) 2003-06-13 2006-03-22 ALTANA Pharma AG Combination de formoterol et ciclesonide
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
EP1803457A1 (fr) * 2005-12-30 2007-07-04 Krka Tovarna Zdravil, D.D., Novo Mesto Composition pharmaceutique contenant du montelukast
PT1976522E (pt) * 2005-12-30 2013-09-09 Krka Tovarna Zdravil D D Novo Mesto Composição farmacêutica contendo montelucaste
WO2007109606A2 (fr) * 2006-03-17 2007-09-27 Csp Technologies, Inc. Emballage primaire étanche à l'humidité pour un inhalateur de poudre sèche
US20110203586A1 (en) * 2008-02-20 2011-08-25 Boehringer Ingelheim International Gmbh Powder Inhalers
JP5809985B2 (ja) 2009-02-26 2015-11-11 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ ４−｛（１ｒ）−２−［（６−｛２−［（２，６−ジクロロベンジル）オキシ］エトキシ｝ヘキシル）アミノ］−１−ヒドロキシエチル｝−２−（ヒドロキシメチル）フェノールを含む医薬製剤
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
CN105603045B (zh) * 2010-01-22 2021-05-14 安晟信医疗科技控股公司 改进准确度的除湿剂
US9233788B2 (en) 2010-01-22 2016-01-12 Bayer Healthcare Llc Biosensor desiccant system having enhanced measurement performance
WO2011093814A2 (fr) * 2010-01-29 2011-08-04 Mahmut Bilgic Compositions pharmaceutiques combinées comprenant du formotérol et du ciclésonide
EP3461474B1 (fr) 2010-08-31 2020-11-11 GlaxoSmithKline Intellectual Property Development Limited Produits médicamenteux pour inhalation sous forme de poudre sèche présentant propriétés de régulation d'humidité et leurs procédés d'administration
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.
TWI565943B (zh) * 2011-07-22 2017-01-11 拜耳保健公司 具有增進測量性能之生物感測器乾燥劑系統
WO2013033623A1 (fr) 2011-09-02 2013-03-07 Nestec S.A. Profilage de protéines de voie de signalisation pour déterminer une efficacité thérapeutique
WO2013109212A1 (fr) * 2012-01-16 2013-07-25 Mahmut Bilgic Formulations en poudre sèche comprenant de la ciclésonide
KR20130140358A (ko) 2012-06-14 2013-12-24 한미약품 주식회사 살메테롤 지나포산염, 플루티카손 프로피오네이트 및 티오트로피움 브로마이드를 포함하는 흡입 제형용 건조 분말 및 이의 제조방법
EP2954329A1 (fr) 2013-02-05 2015-12-16 Nestec S.A. Procédés de sélection d'une polythérapie pour des patients atteints d'un cancer colorectal
CN104644618A (zh) * 2013-11-19 2015-05-27 上海医药工业研究院 一种干粉吸入剂及其制备方法
KR20200125923A (ko) * 2017-10-16 2020-11-05 파에스 파마, 에스.에이. 빌라스틴 및 모메타손을 포함하는 수성 조성물
US10537585B2 (en) 2017-12-18 2020-01-21 Dexcel Pharma Technologies Ltd. Compositions comprising dexamethasone
CN118414147A (zh) * 2021-12-21 2024-07-30 凯西制药公司 填充在具有改善的耐湿性的吸入器中的干粉制剂

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
AU650953B2 (en) * 1991-03-21 1994-07-07 Novartis Ag Inhaler
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5263745A (en) * 1991-06-07 1993-11-23 The United States Of America As Represented By The Secretary Of The Army Plastic tow hitch device
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
EP1102579B1 (fr) * 1998-08-04 2003-03-19 Jago Research Ag Formulations d'aerosol a usage medical
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6352152B1 (en) * 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6119853A (en) 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
GB9928311D0 (en) 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
EP1284771B1 (fr) 2000-05-23 2005-12-14 Glaxo Group Limited Generateur d'aerosol pour formulations de xinafoate de salmeterol
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6472563B1 (en) * 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
RU2326699C2 (ru) * 2001-11-17 2008-06-20 Авентис Фарма Лимитед Адсорбенты и их применение
GB0207899D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
JP2004051502A (ja) * 2002-07-17 2004-02-19 Jcr Pharmaceuticals Co Ltd 成長ホルモン含有安定化粉末製剤
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
US20060293293A1 (en) 2003-05-22 2006-12-28 Altana Pharma Ag Salmeterol and ciclesonide combination
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
NZ544159A (en) * 2003-06-06 2009-04-30 Senesco Technologies Inc Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics
EP1635845A1 (fr) 2003-06-13 2006-03-22 ALTANA Pharma AG Combination de formoterol et ciclesonide
GB0315889D0 (en) * 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
GB0323685D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
US20100247585A1 (en) 2010-09-30
US8440210B2 (en) 2013-05-14
ES2340681T3 (es) 2010-06-08
ATE457163T1 (de) 2010-02-15
MXPA05012757A (es) 2006-02-13
RU2005136869A (ru) 2006-06-10
CN1832890A (zh) 2006-09-13
WO2004105727A2 (fr) 2004-12-09
MA27804A1 (fr) 2006-03-01
US20110308975A1 (en) 2011-12-22
AU2004243223A1 (en) 2004-12-09
EP1626913B1 (fr) 2010-02-10
US8029811B2 (en) 2011-10-04
RS20050882A (sr) 2007-12-31
BRPI0410701A (pt) 2006-06-13
PL1626913T3 (pl) 2010-07-30
US20120247982A1 (en) 2012-10-04
CA2527088A1 (fr) 2004-12-09
GB0312148D0 (en) 2003-07-02
DE602004025463D1 (de) 2010-03-25
EP1626913A2 (fr) 2006-02-22
US20060147537A1 (en) 2006-07-06
ZA200509099B (en) 2006-08-30
JP5175048B2 (ja) 2013-04-03
RU2337667C2 (ru) 2008-11-10
US7736673B2 (en) 2010-06-15
WO2004105727A3 (fr) 2005-06-16
CA2527088C (fr) 2011-03-01
US8163299B2 (en) 2012-04-24
TW200509989A (en) 2005-03-16
KR20060023539A (ko) 2006-03-14
AR047619A1 (es) 2006-02-01
JP2007504277A (ja) 2007-03-01

Similar Documents

Publication Publication Date Title
TW200509989A (en) Stabilized pharmaceutical product
NO20091734L (no) Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse
UA85664C2 (ru) Фармацевтическая лекарственная форма десмопрессина ацетата, способ ее получения, применение и упаковка
NO20051645L (no) Nye aminoindozolderivater som medisin og farmakologiske preparater inneholdende disse
NO20061736L (no) Krystallform av epotilon B
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2003244002A1 (en) Glass plate packing device and method, and package
WO2003087050A3 (fr) Sel de perindopril et les compositions pharmaceutiques qui le contiennent
NO20072661L (no) Rensing av glykopeptider
BRPI0411001A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
BR0214220A (pt) Adsorventes e sua aplicação
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
PA8577701A1 (es) Polipeptido t20 pegilado
AU2003227051A1 (en) Pack for medicine in capsule, pill or similar form
TNSN05330A1 (en) Tablet comprising fluvastatin and carmellose calcium
GB0221169D0 (en) Crystal
WO2005094364A3 (fr) Proteine d'anticorps iga utilisee en tant que medicament cytotoxique
DK1245565T3 (da) Indenoindolon-forbindelse, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NZ533738A (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
AU2002349170A1 (en) Products of natural substance of organic iodine content
GB0306555D0 (en) Display device
ATE401351T1 (de) Lignankomplexe
DK1587810T3 (da) Nye substituerede [1,4]benzodioxino[2,3-e]isoindolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application